Enanta pharmaceuticals, inc. (ENTA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Jun'12Mar'12
Royalty revenue

27,619

52,570

51,313

44,367

39,631

69,886

67,205

57,262

44,049

38,109

75,927

7,511

8,959

10,417

12,841

13,978

13,004

48,445

14,416

11,599

57,367

77,498

2,637

42,051

2,160

893

1,349

1,649

1,196

27,859

2,542

36,565

Operating expenses:
Research and development

32,610

32,778

38,719

34,461

34,155

34,878

26,923

28,487

21,484

17,962

16,514

15,407

13,004

12,526

11,500

10,785

9,143

9,033

7,049

6,253

5,368

4,519

5,202

4,553

4,722

4,263

4,300

4,039

3,704

4,798

4,925

3,263

General and administrative

6,884

6,921

6,163

6,151

6,780

7,152

5,830

6,135

5,706

5,770

5,118

5,233

5,461

4,937

4,440

4,282

4,426

3,818

3,693

3,643

3,438

2,769

2,761

2,603

2,565

2,087

1,750

1,788

1,493

1,152

1,145

1,207

Total operating expenses

39,494

39,699

44,882

40,612

40,935

42,030

32,753

34,622

27,190

23,732

21,632

20,640

18,465

17,463

15,940

15,067

13,569

12,851

10,742

9,896

8,806

7,288

7,963

7,156

7,287

6,350

6,050

5,827

5,197

5,950

6,070

4,470

Income (loss) from operations

-11,875

12,871

6,431

3,755

-1,304

27,856

34,452

22,640

16,859

14,377

54,295

-13,129

-9,506

-7,046

-3,099

-1,089

-565

35,594

3,674

1,703

48,561

70,210

-5,326

34,895

-5,127

-5,457

-4,701

-4,178

-4,001

21,909

-3,528

32,095

Other income (expense):
Interest income (expense), net

1,950

2,076

-

-

2,245

1,885

-

-

-

919

-

617

564

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

549

-

474

408

356

308

304

229

127

138

106

114

109

102

64

47

35

48

15

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

12

-

11

11

12

2

2

2

2

4

5

4

5

8

7

9

7

-

-

Change in fair value of warrant liability and Series 1 nonconvertible preferred stock

-

-

-

-

-

-

-

-

-

41

-114

-17

-15

-13

-15

-16

75

-15

203

-15

-17

176

102

-65

-186

-17

164

-17

214

20

-21

1

Total other income (expense), net

1,950

2,076

2,274

2,415

2,245

1,885

1,429

1,338

1,066

960

-

-

-

524

471

447

472

329

509

287

210

301

236

36

-76

87

258

40

252

48

27

16

Income (loss) before income taxes

-9,925

14,947

8,705

6,170

941

29,741

35,881

23,978

17,925

15,337

54,955

-12,529

-8,957

-6,522

-2,628

-642

-93

35,923

4,183

1,990

48,771

70,511

-5,090

34,931

-5,203

-5,370

-

-4,138

-

-

-

-

Income tax (expense) benefit

-3,920

1,504

-486

-866

-3,204

3,730

8,461

3,690

5,370

3,644

18,447

-4,103

-3,565

-1,542

-826

434

1,552

9,734

-1,629

-428

20,018

28,502

-48

-15,122

0

0

-

-

-

-

-

-

Net income (loss)

-6,005

13,443

9,191

7,036

4,145

26,011

27,420

20,288

12,555

11,693

36,508

-8,426

-5,392

-4,980

-1,802

-1,076

-1,645

26,189

5,812

2,418

28,753

42,009

-5,042

50,053

-5,203

-5,370

-4,443

-4,138

-3,749

21,957

-3,501

32,111

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,244

1,282

1,330

1,331

Net income attributable to participating securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,137

0

0

18,807

-

28,152

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

694

-4,138

-4,993

1,868

-4,831

2,628

Net income (loss) per share:
Basic

-0.30

0.68

0.46

0.36

0.21

1.34

1.43

1.05

0.65

0.61

1.91

-0.44

-0.28

-0.26

-0.10

-0.06

-0.09

1.39

0.30

0.13

1.54

2.26

-0.24

2.70

-0.28

-0.30

0.23

-0.23

-2.28

1.61

-4.31

2.41

Diluted

-0.30

0.65

0.43

0.33

0.20

1.25

1.31

0.97

0.61

0.59

1.89

-0.44

-0.28

-0.26

-0.08

-0.06

-0.09

1.36

0.29

0.13

1.49

2.18

-0.23

2.61

-0.28

-0.30

0.39

-0.23

-2.28

1.45

-4.31

2.17

Weighted average shares outstanding:
Basic

19,922

19,751

19,688

19,673

19,549

19,426

19,381

19,303

19,206

19,130

19,098

19,081

19,047

19,038

19,036

18,983

18,921

18,776

18,711

18,697

18,679

18,603

-54,758

18,528

18,353

17,949

17,981

17,819

2,192

1,158

1,120

1,088

Diluted

19,922

20,773

20,873

21,105

21,084

20,810

21,064

21,017

20,601

19,918

20,462

19,081

19,047

19,038

19,723

18,983

18,921

19,269

19,350

19,277

19,268

19,283

-55,429

19,203

18,353

17,949

16,502

17,819

2,192

2,637

1,120

2,536

Royalties [Member]
Total revenue

-

-

-

44,367

-

-

67,205

57,262

44,049

23,109

10,927

7,511

8,959

10,417

12,841

13,978

13,004

17,869

14,334

11,390

6,961

1,392

-

-

-

-

-

-

-

-

-

-

Milestone [Member]
Total revenue

-

-

-

-

-

-

0

0

0

15,000

-

-

-

-

0

0

0

30,000

0

0

50,000

75,000

-

-

-

-

-

-

-

-

-

-

Other [Member]
Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

576

82

209

406

1,106

-

-

-

-

-

-

-

-

-

-